Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries

Lower availability and affordability of essential CVD medicines were associated with higher risk of MACEs and mortality. Improving access to CVD medicines should be a key part of the strategy to lower CVD globally.